Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers

Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers

Background and Aims. Systemic treatment with sorafenib has been the standard of care (SOC) in patients with advanced Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC) for more than a decade. TACE has been reported to allow better local tumor control in selected patients wit...

Full description

Bibliographic Details
Main Authors: Christine Koch, Markus Göller, Eckart Schott, Oliver Waidmann, Mark op den Winkel, Philipp Paprottka, Stephan Zangos, Thomas Vogl, Wolf Otto Bechstein, Stefan Zeuzem, Frank T. Kolligs, Jörg Trojan
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
HCC
TACE
sorafenib
treatment
Online Access:https://www.mdpi.com/2072-6694/13/9/2121

Internet

https://www.mdpi.com/2072-6694/13/9/2121

Similar Items